BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, September 17, 2024
Home
»
Topics
»
Disease categories and therapies
» Hematologic
Hematologic
RSS
Novel mechanism of action reported for Xenova PAI inhibitor
Dec. 13, 1996
No Comments
Warfarin underused for stroke prevention
Dec. 11, 1996
No Comments
Antithrombin III advances to phase II
Dec. 11, 1996
No Comments
Allelix reports thrombospondin-derived antihemorrhagic peptide
Dec. 11, 1996
No Comments
New thrombin inhibitors under study at Merck & Co.
Dec. 9, 1996
No Comments
Vascular Therapeutics licenses Recordati compound
Dec. 4, 1996
No Comments
Merck reveals new thrombin inhibitor series
Dec. 3, 1996
No Comments
3DP seeks partners for protease inhibitor discovery program
Nov. 29, 1996
No Comments
Merck & Co. reports nonpeptide fibrinogen antagonists with oral activity
Nov. 28, 1996
No Comments
Potent, orally active antiplatelet agent discovered by Merck & Co.
Nov. 28, 1996
No Comments
Previous
1
2
…
446
447
448
449
450
451
452
453
454
…
465
466
Next